The Wall Street JournalJ&J Hit With $8 Billion Jury Award Over Antipsychotic DrugOct 8, 2019Peter LoftusBy Peter Loftusmore_vert
The New York TimesJohnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit (Published 2019)Oct 8, 2019Katie Thomas & Mihir ZaveriBy Katie Thomas & Mihir Zaverimore_vert
USA TODAYJohnson & Johnson ordered to pay $8B in Risperdal gynecomastia caseOct 9, 2019Ryan W. MillerBy Ryan W. Millermore_vert
ReutersJury says J&J must pay $8 billion in case over male breast growth linked to RisperdalOct 8, 2019Brendan Pierson & Nate RaymondBy Brendan Pierson & Nate Raymondmore_vert